Home
About NMSG
Membership
Clinical Trials
Fellowship
Publications
Resources
- Resources
- Upcoming Neuromuscular Meetings
NMSG Meetings

Skip to content

Neuromuscular Study Group

Home
About NMSG
Membership
Clinical Trials
Fellowship
Publications
Resources
- Resources
- Upcoming Neuromuscular Meetings
NMSG Meetings

Using Next Generation Sequencing to Unravel the Pathogenesis of Sporadic Inclusion Body Myositis

Posted on April 7, 2016 by msg-admin

This study is active but not currently enrolling participants.

This entry was posted in MSG Studies, Terminated. Bookmark the permalink.

Search for:

Warning: Undefined array key "pagination" in /home/musclestudy/www/www/wp-content/plugins/list-category-posts/include/lcp-widget.php on line 42

Clinical Trials

Investigating Pompe Prevalence in Neuromuscular Medicine Academic Practices (IPANEMA)
Natural History Study of Spinal Muscular Atrophy (SMA)
Ascorbic Acid Treatment of Charco-Marie Tooth Type 1A (CMT)
Dichlorphenamide vs. Placebo for the Treatment of Patients with Hyperkalemic or Hypokalemic Periodic Paralysis (HYP-HOP)
Efficacy of Prednisone in the Treatment of Ocular Myasthenia (EPITOME)
Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis (MG-SCIg)
Methotrexate in Myasthenia Gravis (Methotrexate)
Using Next Generation Sequencing to Unravel the Pathogenesis of Sporadic Inclusion Body Myositis
Phase 2 Study of Rasagiline for Treatment of Amyotrophic Lateral Sclerosis (Rasagiline)
Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find the Optimum Steroid Regimen (FOR-DMD)
Arimoclomol in Sporadic Inclusion Body Myositis (Arimoclomol)
The International IBM Consortium Genetic Study

Contact Us

Elizabeth Russo Paulk
Neuromuscular Study Group

Site Search

Search for:

Join the Neuromuscular Study Group

© The Neuromuscular Study Group Inc. All rights reserved. Site by Academic Web Pages